Back to Search
WAYNE BATCHELOR, M.D.
M.D.
Interventional Cardiology Physician
NPI: 1639172885IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease Physician
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
0101266323(VA)ME84254(FL)
Interventional Cardiology PhysicianPrimary
Internal Medicine — Interventional Cardiology
Code: 207RI0011X
0101266323(VA)
Education
OTHER
Class of 1990
Research & Publications (14)
Development and validation of a simple model to predict severe coronary artery disease after myocardial infarction: potential impact on cardiac catheterization use in the United States and Canada.
PMID 12595855·Am Heart J·2003
4-observational
Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide.
PMID 12234950·Circulation·2002
3-trial
Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
PMID 19463464·JACC Cardiovasc Interv·2009
4-observational
Clinical and angiographic outcomes in diabetic patients following single or multivessel stenting in the COSTAR II randomized trial.
PMID 18599890·J Invasive Cardiol·2008
4-observational
A campaign to improve the timeliness of primary percutaneous coronary intervention: Door-to-Balloon: An Alliance for Quality.
PMID 19393152·JACC Cardiovasc Interv·2008
6-review
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study.
PMID 18420096·J Am Coll Cardiol·2008
4-observational
Safety and efficacy of only 2 weeks of ticlopidine therapy in patients at increased risk of coronary stent thrombosis: results from the Antiplatelet Therapy alone versus Lovenox plus Antiplatelet therapy in patients at increased risk of Stent Thrombosis (ATLAST) trial.
PMID 12040346·Am Heart J·2002
3-trial
When young hearts are broken: profiles of premature myocardial infarction.
PMID 11773905·Am Heart J·2002
8-other
From COURT to HOMBURG: in search of the optimal contrast agent.
PMID 11603912·Eur Heart J·2001
4-observational
A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial.
PMID 11704394·J Am Coll Cardiol·2001
3-trial
Bleeding risks with abciximab after full-dose thrombolysis in rescue or urgent angioplasty for acute myocardial infarction.
PMID 11174335·Am Heart J·2001
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3300 GALLOWS RD
FALLS CHURCH, VA 22042 - Phone
- (703) 776-4001
Quick Facts
- NPI
- 1639172885
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 36
- Publications
- 14
Are you this provider?
Claim Your Profile